Marie Wikström Lindholm
Technik-/Wissenschafts-/F&E-Leiter bei SILENCE THERAPEUTICS PLC
Aktive Positionen von Marie Wikström Lindholm
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SILENCE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2023 | - |
| Corporate Officer/Principal | 02.11.2020 | 01.12.2023 | |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Direktor/Vorstandsmitglied | 18.01.2022 | - |
Karriereverlauf von Marie Wikström Lindholm
Ehemalige bekannte Positionen von Marie Wikström Lindholm
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Lund | Corporate Officer/Principal | 01.01.1999 | 01.01.2000 |
Ausbildung von Marie Wikström Lindholm
| University of Uppsala | Doctorate Degree |
Statistik
International
| Schweden | 3 |
| Vereinigtes Königreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Commercial Services | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
- Börse
- Insiders
- Marie Wikström Lindholm
- Erfahrung
